Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Metz

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Cardiovascular and Interventional Radiology|October 15, 2016
Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall SurvivalJames X Chen, Steven Rose, Sarah B White, et al.
Pancreas|September 14, 2017
Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective AnalysisBryson W Katona, Giorgio A Roccaro, Michael C Soulen, et al.
The Lancet. Oncology|September 16, 2015
Consensus on biomarkers for neuroendocrine tumour diseaseKjell Oberg, Irvin M Modlin, Wouter De Herder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2020
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide TherapyThomas A Hope, Lisa Bodei, Jennifer A Chan, et al.
American Journal of Medical Genetics. Part A|March 2, 2021
Presacral neuroendocrine tumors associated with the Currarino syndromeAaron T Scott, Jonathon B Tessmann, Terry Braun, et al.
Annals of Surgical Oncology|June 25, 2025
Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine NeoplasmsDavid G Su, Leanne M Brown, Varun V Bansal, et al.
Cancer|June 25, 2025
Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasmsDavid G Su, Leanne M Brown, Varun V Bansal, et al.
Pancreas|September 29, 2020
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine TumorsJennifer R Eads, Diane Reidy-Lagunes, Heloisa P Soares, et al.
Nature Cancer|April 11, 2024
Author Correction: Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissuesZijie Feng, Xin He, Xuyao Zhang, et al.
Nature Cancer|March 22, 2022
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissuesZijie Feng, Xin He, Xuyao Zhang, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Cardiovascular and Interventional Radiology|October 15, 2016
Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall SurvivalJames X Chen, Steven Rose, Sarah B White, et al.
Pancreas|September 14, 2017
Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective AnalysisBryson W Katona, Giorgio A Roccaro, Michael C Soulen, et al.
The Lancet. Oncology|September 16, 2015
Consensus on biomarkers for neuroendocrine tumour diseaseKjell Oberg, Irvin M Modlin, Wouter De Herder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2020
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide TherapyThomas A Hope, Lisa Bodei, Jennifer A Chan, et al.
American Journal of Medical Genetics. Part A|March 2, 2021
Presacral neuroendocrine tumors associated with the Currarino syndromeAaron T Scott, Jonathon B Tessmann, Terry Braun, et al.
Annals of Surgical Oncology|June 25, 2025
Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine NeoplasmsDavid G Su, Leanne M Brown, Varun V Bansal, et al.
Cancer|June 25, 2025
Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasmsDavid G Su, Leanne M Brown, Varun V Bansal, et al.
Pancreas|September 29, 2020
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine TumorsJennifer R Eads, Diane Reidy-Lagunes, Heloisa P Soares, et al.
Nature Cancer|April 11, 2024
Author Correction: Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissuesZijie Feng, Xin He, Xuyao Zhang, et al.
Nature Cancer|March 22, 2022
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissuesZijie Feng, Xin He, Xuyao Zhang, et al.
Pageof 14